Jasper Therapeutics JSPR
NASDAQ JSPR
$0.50 +0.00 (+0.88%)
At close: Oct 21, 2026 · 4:00 PM EDT

Jasper Therapeutics (JSPR) Invested Capital (2022)

Updated

Jasper Therapeutics' Invested Capital came in at $36.01 million for Q4 2022.

Analysis

Jasper Therapeutics (JSPR) Invested Capital (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 88.79 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 134.01 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 64.89 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 95.89 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 51.53 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 82.72 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 68.99 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 38.08 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 148.69 Bn
10 Jasper Therapeutics 14.47 Mn -111.94 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 36.01 Mn
API Access

Jasper Therapeutics Invested Capital API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=invested-capital&ticker=JSPR&period=max&api_key=YOUR_API_KEY